Limitations, agreements, and source contact

Treatment of Primary Hyperparathyroidism With Denosumab and Cinacalcet. · Source last updated 2021-05-25

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

limitations And Caveats

description

Important limitations are the relatively small number of study-participants, and the lack of a cinacalcet monotherapy-arm.

point Of Contact

email

p.vestergaard@rn.dk

organization

Aalborg University Hospital

phone

+45 97 66 36 00

title

Professor Peter Vestergaard

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice